|

KD01(the recombinant oncolytic adenovirus) Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 2

Top Sponsors

  • Tongji Hospital2

Indications

  • Cancer2
  • Gynecologic Malignancies1
  • Bladder Cancer (BC)1
  • Endometrial Cancer1
  • Cervical Cancer1

Other2 trials

Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)
Phase 1
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.